pd 158780 has been researched along with Carcinoma, Squamous Cell in 1 studies
Carcinoma, Squamous Cell: A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rewcastle, GW | 1 |
| Murray, DK | 1 |
| Elliott, WL | 1 |
| Fry, DW | 1 |
| Howard, CT | 1 |
| Nelson, JM | 1 |
| Roberts, BJ | 1 |
| Vincent, PW | 1 |
| Showalter, HD | 1 |
| Winters, RT | 1 |
| Denny, WA | 1 |
1 other study available for pd 158780 and Carcinoma, Squamous Cell
| Article | Year |
|---|---|
Tyrosine kinase inhibitors. 14. Structure-activity relationships for methylamino-substituted derivatives of 4-[(3-bromophenyl)amino]-6-(methylamino)-pyrido[3,4-d]pyrimidine (PD 158780), a potent and specific inhibitor of the tyrosine kinase activity of re
Topics: 3T3 Cells; Animals; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Squamous Cell; Enzyme Inhibi | 1998 |